Core Insights - The "5th Summit Forum on the Development and Cooperation of the Experimental Animal Industry" was successfully held in Nanjing, gathering hundreds of industry experts, scholars, and representatives to discuss the current status, challenges, and future directions of the experimental animal industry [1] Group 1: Industry Development - The forum highlighted the need for efficient collaboration among enterprises, research, and management to promote healthy industry development, emphasizing that growth should not solely focus on scale but also on internal growth and new experiences [2] - The industry faces significant challenges such as resource distribution and standard systems, necessitating breaking down barriers and deepening cooperation to enhance overall technical competitiveness [2] - The experimental animal industry is at a crossroads, transitioning from resource-oriented to technology-driven, with a call for open collaboration and collective innovation to avoid internal competition [2] Group 2: Regional Initiatives - The Nanjing Jiangbei New Area has made strides in building a biopharmaceutical innovation ecosystem and aims to create a trillion-level industrial cluster, recognizing the foundational role of experimental animals in biopharmaceutical research [3] - The area has significantly reduced the approval time for experimental animals through institutional innovation and established a leading global mouse model resource library [3] - Future efforts will focus on policy supply, platform construction, and safety assurance, inviting experts to collaborate in this innovative environment [3] Group 3: Market Outlook - The Chinese experimental animal market is experiencing rapid growth, with animal resources gaining international recognition and the standardization process accelerating [3] - There is a consensus among participants that companies should enhance innovation capabilities, pursue differentiated strategies, and actively explore international markets while deepening industry-academia-research cooperation for efficient result transformation [3] - The forum concluded with a site visit to the facilities of Yaokang Bio, fostering exchanges on facility management, animal welfare, and standardized operations, laying a solid foundation for future collaboration [3]

□ 本报记者张宣实习生卢欣怡 实验动物安抚玩具行业的出现像一面镜子，照出了我国实验动物行业的蜕变。曾经，我们只能跟着国际 标准走；如今，我们不仅能自主研发符合需求的动物福利产品，还建起完整的产业链：从用 CRISPR/Cas9技术定制基因修饰小鼠，到为药企提供药物毒性测试的实验模型，再到集萃药康、南模生 物等企业走向国际，中国已经成了全球实验动物模型资源最丰富的国家之一。 在集萃药康的动物房里，这份"温柔"藏在每一个细节里。"不少单位想建动物房，可没专业技术，建出 来的房子不符合标准，小鼠住得不舒服，实验数据就容易出问题。"集萃药康科研负责人方金龙介绍， 他们会派团队从设计到采购"一管到底"，连温度都用智能系统精准控制，"实验动物得住在SPF(无特定 病原体)环境里，没有有害微生物，空气、水经过严格消毒。只有它们健康，才能给科研提供靠谱的'材 料'。" "科学不断发展，我们不能只盯着'出数据'，也要看到这些小生命的价值。"集萃药康董事长、国家遗传 工程小鼠资源库主任高翔表示，实验动物技术是生物医药创新的基石。目前，公司实验小鼠品系达3万 种左右，稳居全球前列，重点研发人源化动物，满足药企在抗体药物、基因治疗等 ...

Group 1 - The core viewpoint of the news is that the Chengxi Science and Technology Innovation Corridor is experiencing significant growth in industrial value added, particularly in the digital economy sector, which reached 1400.3 billion yuan with a growth rate of 10.6% in the first half of the year [1] - The corridor is focusing on "reform empowerment and innovation deepening," aiming for high-quality integrated development through improved transportation networks and talent innovation mechanisms [1][2] - The corridor has added 5,199 high-level talents in the first half of the year, accounting for 25.7% of the city's new talent, and is promoting collaboration between schools and research institutions to accelerate the commercialization of scientific achievements [1][2] Group 2 - The corridor is set to strengthen its artificial intelligence industry, focusing on key areas such as AI models, intelligent computing, and humanoid robots, while also planning to establish a national-level brain-like computing industry pilot zone [2] - To enhance the integration of technology and finance, the corridor will implement innovative financial policies to support the transformation of scientific achievements and the upgrading of industries, particularly for small and medium-sized technology enterprises [2] - The Chengxi Science and Technology Innovation Corridor aims to deepen the integration of education, technology, and talent development, positioning itself as a key driver of technological innovation in the province [3]

Group 1 - The company plans to use up to RMB 700 million of its idle funds for entrusted wealth management, effective from the board's approval date until the next annual board meeting [1][10][52] - The purpose of the entrusted wealth management is to improve the efficiency of idle funds and increase investment returns for the company and its shareholders [2][9] - The funds for this investment will come from temporarily idle self-owned funds, ensuring that the company's normal operations are not affected [3][4] Group 2 - The investment products will primarily include low-risk, high-security financial products, such as fixed-income products and securities, and will not involve stock investments [4][5] - The board has authorized the management to make investment decisions and sign relevant legal documents, with the finance and funding departments responsible for implementation [5][6] - The company will disclose information regarding the purchase of wealth management products in accordance with the regulations of the Shanghai Stock Exchange [6] Group 3 - The company has also approved changes to certain fundraising projects, including adjustments to investment amounts and project timelines, as well as the addition of new projects [18][19][45] - The project "Mode Animal Mouse R&D Breeding Integrated Base Construction" will have its investment amount reduced from RMB 611.13 million to RMB 430.26 million, and the expected completion date will be extended to April 2030 [21][45] - A new project, "AI-driven Organoid and Animal Disease Model Multi-modal Preclinical Drug Research Platform," with an investment of RMB 200 million, has been introduced to enhance the company's R&D capabilities [24][45]